| 000 | 00798 a2200217 4500 | ||
|---|---|---|---|
| 005 | 20250517132659.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a1198-0052 | ||
| 024 | 7 |
_a10.3747/co.23.3430 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBharmal, A | |
| 245 | 0 | 0 |
_aControlled settings for lung cancer screening: why do they matter? Considerations for referring clinicians. _h[electronic resource] |
| 260 |
_bCurrent oncology (Toronto, Ont.) _cDec 2016 |
||
| 300 |
_a371-373 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aCrosskill, A | |
| 700 | 1 | _aLam, S | |
| 700 | 1 | _aBryant, H | |
| 773 | 0 |
_tCurrent oncology (Toronto, Ont.) _gvol. 23 _gno. 6 _gp. 371-373 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3747/co.23.3430 _zAvailable from publisher's website |
| 999 |
_c26750621 _d26750621 |
||